Clinical efficacy of ciprofloxacin in patients with respiratory tract infection refractory to penicillin or cephem: Carbapenem-controlled clinical study

Keyphrases

• Respiratory Infection 100%
• Clinical Efficacy 100%
• Controlled Experiment 100%
• Penicillin 100%
• Ciprofloxacin 100%
• Carbapenems 100%
• Cephem 100%
• Between-group 30%
• Length of Hospital Stay 20%
• Intravenous Infusion 20%
• Antibacterial Therapy 20%
• Adverse Events 10%
• Clinical Application 10%
• No Significant Difference 10%
• Number of Patients 10%
• Japan 10%
• Causal Relationship 10%
• Efficacy Analysis 10%
• Adverse Drug Reaction 10%
• Safety Self-efficacy 10%
• Pneumonia 10%
• New Treatment Options 10%
• Improvement Factor 10%
• Safety Analysis 10%
• Early Improvement 10%
• Duration of Therapy 10%
• Infection Diagnosis 10%
• Serious Adverse Reaction 10%
• Sex Ratio 10%
• Infection Severity 10%
• Acute Respiratory Tract Infection 10%
• Antibacterial Agents 10%
• New Quinolone 10%
• Penicillin Antibiotics 10%
• Cephem Antibiotics 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Respiratory Tract Infection 100%
• Clinical Study 100%
• Ciprofloxacin 100%
• Penicillin Derivative 100%
• Carbapenem 100%
• Cephem 100%
• Adverse Event 20%
• Infection 20%
• Antibacterial Therapy 20%
• Antiinfective Agent 10%
• Adverse Drug Reaction 10%
• Antibiotics 10%
• Quinolone 10%